Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members

BMC Cancer

Table 1 Clinico-pathological features of the analysed tumour cases

Case	Histology	Fusion status	Primary site	Clinical stage
ARMS1*	alveolar	PAX3	trunk	III
ARMS2*	alveolar	PAX3	extremity	III
ARMS3*	alveolar	negative	trunk	II
ARMS4*	alveolar	PAX7	uterus-vagina	III
ARMS7	alveolar	PAX3	extremity	IV
ARMS36	alveolar	PAX3	trunk	III
ARMS37	alveolar	PAX3	uterus-vagina	II
ERMS1*	embryonal	n.a.	retroperitoneum	III
ERMS2*	embryonal	n.a.	bladder-prostate	III
ERMS3*	embryonal	n.a.	bladder-prostate	III
ERMS4*	embryonal	n.a.	trunk	III
ERMS12	embryonal	n.a.	bladder-prostate	III
ERMS21	embryonal	n.a.	retroperitoneum	III
ERMS23	embryonal	n.a.	uterus-vagina	II
ERMS27	embryonal	n.a.	extremity	I

Variables were categorized as follows: histological subtype, embryonal versus alveolar; gene fusion status; primary site and clinical stage. Fusion status PAX3: PAX3-FOXO1–positive; PAX7: PAX7-FOXO1–positive ; n.a. - not applicable. The symbol * indicates samples used for deep sequencing analysis.

ISSN: 1471-2407